Abstract
The effect of angiotensin ii receptor blocker valsartan on the level of circulating endothelial progenitor cells in diabetic patients with chronic heart failure
Highlights
O.O.Kremzer – Candidate of Medicine, associate professor of the Department of Clinical Pharmacology, Clinical Pharmacy with Cosmetology Course of the Zaporizhzhia State Medical University al effects of different modes of therapy in relation to short-term and long-term prognosis
The aim of this study was to assess the effect of angiotensin II receptor blocker valsartan on the circulating level of endothelial progenitor cells in patients with ischemic chronic heart failure in combination with type two diabetes mellitus (T2DM)
CLINICAL PHARMACY. – 2014. – Vol 18, No 3 (LVEF) ≤ 40 %; severe kidney and liver diseases, which may affect the clinical outcome; unstable angina, myocardial infarction, or intracranial hemorrhage within 30 days prior to the study; the level of plasma creatinine above 440 mmol/l; the glomerular filtration rate (GFR) < 35 mL/min/m2; the body mass index above 30 kg/m2; hemodynamically significant tachyarrhythmias; valvular heart disease; hyperthyroidism; all cardiovascular ischemic events occurred during three months preceding the beginning of the research; cancer; cardiac pacemakers; pregnancy
Summary
The aim of this study was to assess the effect of angiotensin II receptor blocker valsartan on the circulating level of endothelial progenitor cells in patients with ischemic chronic heart failure in combination with type two diabetes mellitus (T2DM)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
